Rebecca Araujo

DocwireNews

New guidelines from the International Osteoporosis Foundation (IOF) address management of osteoporosis, fracture risk, and overall bone health among patients receiving autologous hematopoietic cell transplantation (AHCT).AHCT is a common therapy for patients with hematologic malignancies, including multiple myeloma.&ldquo;Unfortunately, too many AHCT recipients are not being monitored and treated for bone fragility, despite the fact that poor bone health is a significant comorbidity post-AHCT,&rdquo; said Nicholas Harvey, PhD, Chair of the IOF Committee of Scientific Advisors, via a <a href="https://www.eurekalert.org/pub_releases/2021-05/iof-htm050321.php">press release</a>. &ldquo;We therefore urge all physicians who care for AHCT recipients to take action to protect their patients&rsquo; long-term bone health. It is important to keep in mind that fragility fractures can be severely debilitating, with resulting loss of physical independence and quality of life.&rdquo;The IOF guidelines recommend increased monitoring of bone fragility among this patient population, and administration of osteoporosis treatments for patients that are identified to be at high risk of bone loss or fracture. Post-transplant dual energy X-ray absorptiometry is encouraged to assess bone mineral density to determine patient risk. Other recommendations include lifestyle changes to promote bone health, such as a diet with adequate amounts of calcium, protein, and Vitamin D; a muscle-strengthening exercise regimen; and avoidance of tobacco and alcohol.&ldquo;This concise summary aims to encourage and assist hematologists and oncologists in addressing osteoporosis and fracture prevention in their AHCT patients,&rdquo; said Ren&eacute; Rizzoli, MD, PhD, Chair of the IOF Cancer and Bone Working Group. &ldquo;The &lsquo;check list&rsquo; includes bone mineral density examination, evaluation of clinical risk factors, and general dietary and physical activity measures, with appropriate application of osteoporosis pharmacotherapies in those who are found to be at increased high risk of fracture.&rdquo;These guidelines were published in the <a href="https://www.sciencedirect.com/science/article/pii/S2212137421000154">Journal of Bone Oncology</a>.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Supporting Bone Health in Patients Receiving Stem Cell Transplant

Oncology

New guidelines from the International Osteoporosis Foundation (IOF) address management of osteoporosis, fracture risk, and overall bone health among patients receiving ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe